![]() |
市場調査レポート
商品コード
1588576
体液管理モニタリングシステムの世界市場:2024年~2031年Global Fluid Management Monitoring System Market - 2024-2031 |
||||||
カスタマイズ可能
適宜更新あり
|
体液管理モニタリングシステムの世界市場:2024年~2031年 |
出版日: 2024年11月08日
発行: DataM Intelligence
ページ情報: 英文 202 Pages
納期: 即日から翌営業日
|
概要
世界の体液管理モニタリングシステム市場は、2023年に19億6,000万米ドルに達し、2031年には34億3,000万米ドルに達すると予測され、予測期間2024-2031年のCAGRは6.5%で成長する見込みです。
輸液管理のプロセスは、医療において最も複雑な分野の一つであり、特に患者一人ひとりのニーズを重視する入院患者においてはなおさらです。多くの場合、特に寝たきりの患者では、水分補給のコントロールの信頼性が損なわれ、その結果、罹患率が高くなり、死亡率さえも高くなります。したがって、輸液管理は、失われた輸液を含む生理的ニーズを満たすものであり、非常に重要です。
促進要因と抑制要因
慢性疾患の有病率の上昇
体液管理モニタリングシステムの世界マーケットプレースは、腎臓病、心不全、糖尿病などの慢性疾患の患者数の増加により、著しい成長を見せています。このような疾患では、合併症を回避し良好な結果を得るために、慎重かつ正確なモニタリングが必要となります。このような投資により、ヘルスケアプロバイダーは、タイムリーでより良い最終結果を得るために、リアルタイムで正確なデータを提供するハイエンドシステムを購入しています。
人口の高齢化とライフスタイルの動向に伴い、慢性疾患の有病率が世界の舞台で増加するにつれ、体液管理制御のための信頼できるソリューションの必要性が高まり、多くの患者の複雑なケアに対応するために、これらのシステムをサポートすることが予測されます。
例えば、メイヨークリニック2023によると、感染性疾患と非感染性疾患との間の移行は、公衆衛生の改善により1900年代初頭に始まった。個人の寿命が延びるにつれ、慢性疾患の罹患率とコストは増加の一途をたどり、2030年には47兆ドルに達すると推定されています。個人のライフスタイル、行動、地域社会の要因は、慢性疾患の発症と管理に大きく影響します。
体液管理モニタリングシステムの高コスト
世界の体液管理モニタリングシステム市場は厳しい競合から免れることはできないが、その主な原因は、特に病院が資源と予算の制約に対処している新興国地域において、高いコストがかかることにあります。体液問題を抱える患者の効果的な管理に必要であっても、このような財政的な制約があるため、これらの高度な機器を大規模に導入することができないです。また、資源が乏しい環境では、メンテナンス、トレーニング、ソフトウェアのアップグレードなどにかかる費用が、この技術の利用を制限しています。
例えば、HysteroLux体液管理システム・コントロール・ユニットの価格は、他社製品と同様に約4,000~1万米ドルであり、予測期間中に市場全体が成長する妨げとなっています。
Overview
The global fluid management monitoring system market reached US$ 1.96 billion in 2023 and is expected to reach US$ 3.43 billion by 2031, growing at a CAGR of 6.5% during the forecast period 2024-2031.
The process of fluid management is one of the most complicated areas in medicine, especially in an inpatient setting that emphasizes the individual needs of each patient. In many instances, especially in patients that are confined to bed, the reliability of the control of hydration is impaired, with resultant high morbidity and even mortality. Fluid management, therefore, is very important because it satisfies the physiological needs, including fluids that are lost.
Market Dynamics: Drivers & Restraints
Rise in the Prevalence of Chronic Diseases
The worldwide marketplace for fluid management monitoring systems is seeing tremendous growth owing to the rising cases of chronic diseases, such as kidney disease, heart failure, diabetes, and others. Such diseases require careful and exact monitoring in order to avoid complications and ensure positive results. With such investments, healthcare providers are purchasing high-end systems that provide accurate data in real-time for timely and better end results.
As the prevalence of chronic diseases increases on the global stage with the growing aging population and lifestyle trends, the need for dependable solutions for fluid management control is projected to increase hence making these systems supportive in dealing with the care complexity of most patients.
For instance, according to Mayo Clinic 2023, the transition between infectious and noncommunicable diseases began in the early 1900s due to improved public health. As individuals live longer, chronic disease prevalence and cost continue to rise, with the estimated cost reaching $47 trillion by 2030. Individual lifestyle, behaviors, and community factors significantly influence the development and management of chronic diseases.
High costs of Fluid Management Monitoring System systems
The global fluid management monitoring systems market is not spared from the stiff competition, mostly due to the high costs involved especially in developing regions where hospitals deal with resource and budget constraints. This financial limit prevents a large-scale implementation of these advanced equipment, even when they are needed for effective management of patients with fluid problems. Also, in low resource environments, the cost of maintenance, training, and software upgrades, etc. limits the access of this technology.
For instance, HysteroLux Fluid Management System Control Unit costs around U$ 4000-10,000 like this other company products cost varies high which hinders the overall market to grow during the forecast period.
The global fluid management monitoring system market is segmented based on product type, , application, end user, distribution channel and region.
Fluid management devices segment is expected to dominate the market share
The fluid management devices segment are expected to hold a significant portion of the market share. In healthcare environments such as the operating theatre, the emergency department, and the intensive care unit, fluid management devices play an important role in controlling and measuring patient's fluid saturation levels. They allow for the monitoring of the data in real-time thereby minimizing the chances of over hydration or dehydration of a patient.
The development of technology incorporated solid state devices to allow collection, analysis of data, and easy interaction with EHR'S (Electronic Health Records) enhancing clarity of medical decisions and increasing the recovery chances in patients. Rising occurrences of chronic illnesses, geriatric populace, and less invasive surgical procedures are stimulating the uptake of these devices, making them essential devices in the system for fluid management monitoring market.
For instance, in August 2024, Watson-Marlow Fluid Technology Solutions (WMFTS) has launched WMArchitect, a flexible, single-use solution for biopharmaceutical fluid management. The platform builds on previous products like puresu and asepticsu, aiming to streamline processes, protect products, and reduce regulatory burden.
North America is expected to hold a significant position in the fluid management monitoring system market share
North America is expected to hold a significant position in the global Fluid Management Monitoring System market during the forecast period due to the rapid growth in the geriatric population, the rise in chronic diseases, FDA clearance, the increase in research and development, an increase in technology and many more. Higher living standards and the rise in the number of people suffering from cancer has brought about an increase in demand for fluid administration systems, disposable accessories and also for minimally invasive surgeries.
For instance, in April 2024, Baxter International has received FDA 510(k) clearance for its Novum IQ large volume infusion pump (LVP) with Dose IQ Safety Software. This addition to the Novum IQ Infusion Platform, which includes Baxter's syringe infusion pump (SYR) with Dose IQ Safety Software, allows clinicians to use a single, integrated system across various patient care settings. Baxter's commitment to innovation in infusion therapy is demonstrated by offering the Novum IQ LVP in the U.S.
Moreover, in August 2022, Zynex, a medical technology company, has started enrolling in an ongoing apheresis clinical trial using its second-generation fluid monitoring system, the CM-1600. The study uses the CM-1500 and CM-1600 devices during an apheresis procedure to refine the system's patented Relative Index.
The major global players in the market include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, Cardinal Health, Inc., Stryker Corporation,B. Braun Melsungen AG, Medtronic plc, Olympus Corporation, Smiths Medical, Ecolab Inc, KARL STORZ GmbH & Co. KG among others.
The global fluid management monitoring system market report would provide approximately 70 tables, 69 figures, and 202 pages.
LIST NOT EXHAUSTIVE